Although molecular studies were not conducted to confirm underlying SMARCB1 alterations, emerging evidence underscores INI-1 (SMARCB1) loss, as detected by IHC, as the most defining and consistently reproducible feature of these neoplasms (1, 27). Here, SMARCB1 is linked to neoplasm.